$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000087786017000065 Filed on August 09, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$69.84M	$61.20M
YoY Change	14.1%	8.69%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.930M	$2.520M
YoY Change	16.27%	-6.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$16.82M	$14.70M
YoY Change	14.45%	13.0%
% of Gross Profit
Operating Expenses	$31.49M	$42.60M
YoY Change	-26.1%	73.14%
Operating Profit	$38.34M	$18.60M
YoY Change	106.13%
Interest Expense	$11.73M	$10.67M
YoY Change	9.99%	14.85%
% of Operating Profit	30.6%	57.34%
Other Income/Expense, Net		$20.00K
YoY Change
Pretax Income	$38.24M	$18.60M
YoY Change	105.59%	-41.34%
Income Tax
% Of Pretax Income
Net Earnings	$38.25M	$44.60M
YoY Change	-14.24%	43.02%
Net Earnings / Revenue	54.76%	72.86%
Basic Earnings Per Share	$0.93	$1.16
Diluted Earnings Per Share	$0.93	$1.16
COMMON SHARES
Basic Shares Outstanding	40.98M shares	38.52M shares
Diluted Shares Outstanding	41.25M shares	38.56M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.926M	$27.63M
YoY Change	-85.79%	53.85%
Cash & Equivalents	$3.926M	$3.876M
Short-Term Investments	$0.00	$23.75M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$3.800M	$3.900M
Other Receivables	$83.20M	$62.00M
Total Short-Term Assets	$90.50M	$69.80M
YoY Change	29.66%	29.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.267B	$2.066B
YoY Change	9.72%	18.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$7.197M
YoY Change		-19.23%
Other Assets	$4.400M	$8.600M
YoY Change	-48.84%	-74.85%
Total Long-Term Assets	$2.421B	$2.266B
YoY Change	6.84%	15.65%
TOTAL ASSETS
Total Short-Term Assets	$90.50M	$69.80M
Total Long-Term Assets	$2.421B	$2.266B
Total Assets	$2.511B	$2.335B
YoY Change	7.52%	16.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.30M	$26.20M
YoY Change	-30.15%	81.94%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$79.60M	$82.70M
YoY Change	-3.75%	22.34%
LONG-TERM LIABILITIES
Long-Term Debt	$1.145B	$1.073B
YoY Change	6.73%	20.13%
Other Long-Term Liabilities		$1.200M
YoY Change		-78.57%
Total Long-Term Liabilities	$1.145B	$1.074B
YoY Change	6.61%	19.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$79.60M	$82.70M
Total Long-Term Liabilities	$1.145B	$1.074B
Total Liabilities	$1.225B	$1.157B
YoY Change	5.86%	19.71%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.255B	$1.136B
YoY Change	10.46%	9.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.286B	$1.170B
YoY Change
Total Liabilities & Shareholders Equity	$2.511B	$2.335B
YoY Change	7.52%	16.03%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$38.25M	$44.60M
YoY Change	-14.24%	43.02%
Depreciation, Depletion And Amortization	$16.82M	$14.70M
YoY Change	14.45%	13.0%
Cash From Operating Activities	$46.20M	$41.90M
YoY Change	10.26%	1.21%
INVESTING ACTIVITIES
Capital Expenditures	-$10.40M	-$252.1M
YoY Change	-95.87%	252000.0%
Acquisitions
YoY Change
Other Investing Activities	$2.900M	$35.90M
YoY Change	-91.92%	-1595.83%
Cash From Investing Activities	-$7.500M	-$216.2M
YoY Change	-96.53%	8908.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-41.00M	149.4M
YoY Change	-127.44%	-474.44%
NET CHANGE
Cash From Operating Activities	46.20M	41.90M
Cash From Investing Activities	-7.500M	-216.2M
Cash From Financing Activities	-41.00M	149.4M
Net Change In Cash	-2.300M	-24.90M
YoY Change	-90.76%	2666.67%
FREE CASH FLOW
Cash From Operating Activities	$46.20M	$41.90M
Capital Expenditures	-$10.40M	-$252.1M
Free Cash Flow	$56.60M	$294.0M
YoY Change	-80.75%	608.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40986651	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2016Q4	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	9017000	USD
CY2017Q2	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	3753000	USD
CY2016Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	871000	USD
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1739000	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	349000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1772000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2479000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41773	shares
	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	20000	shares
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	770000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	283000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	109000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2321000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	866000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2017Q2	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	869000	USD
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1774000	USD
	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	1.80
	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	1.90
CY2017Q2	nhi	Contingent Funding Commitment ContingentFundingCommitment	27430000	USD
CY2017Q2	nhi	Contingent Funding Commitment Remaining Unfunded Amount ContingentFundingCommitmentRemainingUnfundedAmount	25430000	USD
CY2017Q1	nhi	Convertible Debt Instrument Conversion Ratio Principal Amount Basis ConvertibleDebtInstrumentConversionRatioPrincipalAmountBasis	1000	USD
CY2017Q2	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
	nhi	Debt Instrument Variable Rate Basis Minimum DebtInstrumentVariableRateBasisMinimum	0
CY2016Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	273000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	555000	USD
CY2017Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	267000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	534000	USD
CY2016Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	0	USD
CY2017Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	1250000	USD
CY2016Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	14726000	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	14726000	USD
CY2017Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
CY2017Q2	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	129800000	USD
CY2017Q2	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	1278000	USD
CY2017Q2	nhi	Notes Receivable Funding Commitment NotesReceivableFundingCommitment	41261000	USD
CY2017Q2	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	8	properties
CY2017Q2	nhi	Number Of Lessees NumberOfLessees	29
CY2017Q2	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2611526000	USD
	nhi	Real Estate Investments During The Period RealEstateInvestmentsDuringThePeriod	129661000	USD
CY2017Q2	nhi	Remaining Unfunded Development Commitment RemainingUnfundedDevelopmentCommitment	53112000	USD
CY2017Q2	nhi	Variable Interest Entity Number Of Entities Not Primary Beneficiary VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary	7
	nhi	Write Off Of Straight Line Rent Receivable WriteOffOfStraightLineRentReceivable	14726000	USD
	nhi	Write Off Of Straight Line Rent Receivable WriteOffOfStraightLineRentReceivable	0	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	20874000	USD
CY2017Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	18301000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	313080000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	345992000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5731000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3124000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1173588000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1254516000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	360000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-337000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1230000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1865000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	143000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14940	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11015	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9736	shares
CY2016Q4	us-gaap	Assets Assets	2403633000	USD
CY2017Q2	us-gaap	Assets Assets	2511042000	USD
CY2017Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1680000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13286000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3876000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4832000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3470000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3470000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9410000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1362000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.95
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.90
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39847860	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40984289	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39847860	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40984289	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	398000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	410000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24401000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	55484000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	38200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73620000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	386000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	770000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	24787000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	56254000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	38200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	73620000	USD
	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	76688000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	15729000	USD
CY2017Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	20201000	USD
CY2014Q1	us-gaap	Convertible Debt ConvertibleDebt	189908000	USD
CY2016Q4	us-gaap	Convertible Debt ConvertibleDebt	195283000	USD
CY2017Q2	us-gaap	Convertible Debt ConvertibleDebt	193477000	USD
CY2016Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	29873000	USD
CY2017Q2	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	34624000	USD
CY2017Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1159106000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7667000	USD
CY2017Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	70.58
CY2017Q1	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	14.17
CY2017Q1	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	24118000	USD
CY2017Q1	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	2799150	shares
CY2017Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5542000	USD
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8559000	USD
CY2016Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1115981000	USD
CY2017Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1145005000	USD
CY2016Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	72518000	USD
CY2017Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	83273000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	14695000	USD
	us-gaap	Depreciation Depreciation	28429000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	16829000	USD
	us-gaap	Depreciation Depreciation	32983000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	77724000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35863000	USD
CY2017Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	38935000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.01
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.04
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.01
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1302000	USD
CY2016Q4	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2017Q2	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	4500000	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	26415000	USD
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	28080000	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	10088000	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	4582000	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	50000	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-96000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-96000	USD
CY2016Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2928000	USD
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	4582000	USD
CY2017Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	50000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2120000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5048000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2211000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2521000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6630000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.16
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.93
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.01
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.93
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.03
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-57000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-460000	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2016Q2	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-23000	USD
	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-184000	USD
CY2017Q2	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	0	USD
	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	147420	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	196792	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	147420	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	41163	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	27154	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	66137	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	63901	shares
CY2015Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	316000	USD
CY2016Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	160000	USD
CY2016Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	196000	USD
CY2017Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	94000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	10666000	USD
	us-gaap	Interest Expense InterestExpense	20928000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	11828000	USD
	us-gaap	Interest Expense InterestExpense	23489000	USD
CY2016Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9991000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	19505000	USD
CY2017Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10957000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	21779000	USD
CY2016Q2	us-gaap	Interest Income Operating InterestIncomeOperating	3307000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	6468000	USD
CY2017Q2	us-gaap	Interest Income Operating InterestIncomeOperating	3992000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	7081000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	19057000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	21763000	USD
CY2016Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2285122000	USD
CY2017Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2408660000	USD
CY2016Q4	us-gaap	Land Land	172003000	USD
CY2017Q2	us-gaap	Land Land	183943000	USD
CY2016Q2	us-gaap	Legal Fees LegalFees	124000	USD
	us-gaap	Legal Fees LegalFees	250000	USD
CY2017Q2	us-gaap	Legal Fees LegalFees	146000	USD
	us-gaap	Legal Fees LegalFees	202000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1194043000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	1224616000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2403633000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2511042000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	158000000	USD
CY2017Q2	us-gaap	Line Of Credit LineOfCredit	188000000	USD
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-157000000	USD
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-30000000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
CY2017Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	20
	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	117000000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	133493000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	141107000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	808000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	519209000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	923000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	198468000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	835000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	438863000	USD
CY2016Q4	us-gaap	Marketable Securities MarketableSecurities	11745000	USD
CY2017Q2	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2016Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	23487000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	23498000	USD
CY2017Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	10038000	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	23498000	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	10038000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	137920000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31601000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-230525000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127911000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	83195000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94948000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	44595000	USD
	us-gaap	Net Income Loss NetIncomeLoss	77320000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	38245000	USD
	us-gaap	Net Income Loss NetIncomeLoss	82475000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000	USD
CY2017Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	65735000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1475000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	598000	USD
CY2017Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	207	properties
CY2017Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	42604000	USD
	us-gaap	Operating Expenses OperatingExpenses	69936000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	31591000	USD
	us-gaap	Operating Expenses OperatingExpenses	63838000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	18600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	50286000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	38245000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	72387000	USD
CY2016Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	57028000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	112102000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	128873000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	33016000	USD
CY2017Q2	us-gaap	Other Assets OtherAssets	16380000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20194000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21836000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8855000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	23487000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	23498000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	10038000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-1004000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-2017000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-645000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-1434000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-2331000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-7811000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-690000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-225000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4620000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7456000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-26000	USD
CY2016Q2	us-gaap	Other Income OtherIncome	869000	USD
	us-gaap	Other Income OtherIncome	1652000	USD
CY2017Q2	us-gaap	Other Income OtherIncome	109000	USD
	us-gaap	Other Income OtherIncome	271000	USD
	us-gaap	Other Noncash Income OtherNoncashIncome	386000	USD
	us-gaap	Other Noncash Income OtherNoncashIncome	470000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	8446000	USD
CY2016Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	26415000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	28080000	USD
CY2017Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10088000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	815000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2891000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	67201000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	74651000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	822000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	360000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6400000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	41673000	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	30950000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	261610000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	128411000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	15554000	USD
CY2017Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	197575000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50190000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	79772000	USD
	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	27723000	USD
	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	450000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	15855000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	24155000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	56449000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18182000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	44981000	USD
	us-gaap	Profit Loss ProfitLoss	78090000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	38245000	USD
	us-gaap	Profit Loss ProfitLoss	82475000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2472854000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2612804000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2159774000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2266812000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2766000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	381000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	394000	USD
CY2016Q4	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4046000	USD
CY2017Q2	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4419000	USD
CY2016Q2	us-gaap	Revenues Revenues	61204000	USD
	us-gaap	Revenues Revenues	120222000	USD
CY2017Q2	us-gaap	Revenues Revenues	69836000	USD
	us-gaap	Revenues Revenues	136225000	USD
CY2016Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21325000	USD
CY2017Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	22375000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1865000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.062
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.053
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.191
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.197
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0091
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	406660	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	540830	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.65
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.75
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	741676	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	760008	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	541679	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	934181	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M4D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y4M0D
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	79772000	USD
CY2016Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	251000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1230000	USD
CY2017Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	342000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1865000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1209590000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1286426000	USD
	us-gaap	Straight Line Rent StraightLineRent	10583000	USD
	us-gaap	Straight Line Rent StraightLineRent	12005000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9740000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	38520221	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	38460934	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	40982244	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	40468024	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38561384	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38488088	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41245173	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40679345	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38520221	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38460934	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40982244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40468024	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified certain balances where necessary to conform the presentation of prior periods to the current period. We have combined our investment in marketable securities into other assets in our Condensed Consolidated Balance Sheets.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-17-000065-index-headers.html	Edgar Link	pending
0000877860-17-000065-index.html	Edgar Link	pending
0000877860-17-000065.txt	Edgar Link	pending
0000877860-17-000065-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20170630.xml	Edgar Link	completed
nhi-20170630.xsd	Edgar Link	pending
nhi-20170630_cal.xml	Edgar Link	unprocessable
nhi-20170630_def.xml	Edgar Link	unprocessable
nhi-20170630_lab.xml	Edgar Link	unprocessable
nhi-20170630_pre.xml	Edgar Link	unprocessable
nhi-6302017x10q.htm	Edgar Link	pending
nhi-6302017x10qex311.htm	Edgar Link	pending
nhi-6302017x10qex312.htm	Edgar Link	pending
nhi-6302017x10qex32.htm	Edgar Link	pending
nhi2017creditagreement2205.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wellslogoa01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2017 Q2 Form 10-Q Financial Statement

#000087786017000065 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2017 Q2 Form 10-Q Financial Statement

#000087786017000065 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi